Fcpm Iii Services B.v. »

Maplight Therapeutics shares owned by Fcpm Iii Services B.v.

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Fcpm Iii Services B.v. from 13F filings

Historical chart of Fcpm Iii Services B.v. investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Fcpm Iii Services B.v. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Fcpm Iii Services B.v.

Quarter filed Position value Share count Share price at filing
2025-12-31 $57M 3.2M 17.57

More positions owned by Fcpm Iii Services B.v.

Newamsterdam Pharma Company Ordinary Shares (NAMS)
Dyne Therapeutics (DYN)
Engene Holdings (ENGN)
Rapt Therapeutics Com New (RAPT)
Maplight Therapeutics (MPLT)
Vor Biopharma Com New (VOR)
Replimune Group (REPL)
Bicycle Therapeutics Sponsored Ads (BCYC)
Crescent Biopharma (CBIO)
Engene Holdings W Exp 10/31/2028 (ENGNW)

View all positions for Fcpm Iii Services B.v.

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
Nan Fung Group Holdings
5AM Venture Management
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Geode Capital Management
Blue Owl Capital Holdings
State Street Corporation
Lazard Asset Management
Board of Trustees of The Leland Stanford Junior University
Freestone Grove Partners

View all funds holding Maplight Therapeutics